Health Catalyst, Inc. (HCAT) company profile
Close on Nov 17, 2026Market cap $103.10MP/E –Yield –
About Health Catalyst
Services-Computer Programming, Data Processing, Etc., SIC 7370
Health Catalyst provides data and analytics technology alongside professional services to healthcare organizations. The company's primary solution integrates its proprietary cloud-based Ignite data platform with software applications and domain expertise. Its software applications cover several focus areas, including clinical improvement, revenue and cost enhancement, ambulatory operations, regulatory measures and registries, and data management. In addition to software, the company delivers implementation support, data science consulting, and tech-enabled managed services. Health Catalyst primarily serves healthcare providers and related organizations, including integrated delivery networks, academic medical centers, community hospitals, physician practices, accountable care organizations, health insurers, and health information exchanges.
The company operates primarily across the United States and maintains an international presence in the United Kingdom, Singapore, and a small number of other countries. As of December 31, 2025, Health Catalyst served 162 platform clients and more than 1,000 application clients, supported by a workforce of over 950 analytics and domain professionals. The provided text does not mention the location of its headquarters.
Summary of the business section of Health Catalyst's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Health Catalyst, Inc.
- Headquarters
- South Jordan, UT
- Address
- 10897 South River Front Parkway, #300 84095
- Phone
- (801) 708-6800
- Website
- healthcatalyst.com
- Employees
- 1,200, Dec 31, 2025
- Industry
- Services-Computer Programming, Data Processing, Etc.
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- Ernst & Young LLP, Salt Lake City, Utah
Stock & identifiers
- Ticker
- HCAT
- Exchange
- Nasdaq
- IPO date
- Jul 25, 2019
- Shares outstanding
- 75M, Jul 31, 2026
- Public float
- $259.00M, Dec 31, 2025
- Filer category
- Accelerated filer
- SEC CIK
- 1636422
- CUSIP
- 42225T107
- ISIN
- US42225T1079
- FIGI
- BBG00LDPZMS6
- Share class FIGI
- BBG00LDPZMT5
- LEI
- 549300223PL6GWKVJG92
- EIN
- 45-3337483
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Simeon Kohl | Chief Executive Officer, Director | 25,000 |
| Benjamin Albert | CEO, Director | 1,417,103 |
| Daniel D. Burton | Chief Executive Officer, Director | 1,393,099 |
| Benjamin Landry | General Counsel | 251,894 |
| Jason Alger | Chief Financial Officer | 704,867 |
| Linda Llewelyn | Chief People Officer | 321,132 |
| Kevin Lee Freeman | Chief Commercial Officer | 358,686 |
| Daniel LeSueur | Chief Operating Officer | 198,367 |
| David Coy Ross | Chief Tech & Product Officer | 204,219 |
| Tami Reller | Director | 128,851 |
| Julie Larson-Green | Director | 185,101 |
| Justin Spencer | Director | 149,263 |
| Steven H. Nelson | Director | 235,499 |
| Green Jill Hoggard | Director | 144,628 |
| Duncan Gallagher | Director | 132,023 |
| Mathew Paul Arens | Director | – |
| S. Dawn Smith | Director | 101,692 |
| John A. Kane | Director | 170,719 |
| Anita Pramoda | Director | 62,503 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 | $3.99M | $268.06K | $1.99M | $5 | $99 |
| FY2024 | $5.49M | $4.17M | $1.45M | $20 | $105 |
| FY2023 | $0 | -$59.15K | $1.22M | $27 | $106 |
| FY2022 | $4.44M | -$8.15M | $3.19M | $31 | $100 |
| FY2021 | $5.96M | $5.62M | $3.30M | $114 | $125 |
| FY2020 | $5.48M | $9.79M | $2.38M | $125 | $130 |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Executive compensation, fiscal 2025
Summary compensation table from the latest proxy statement
| Executive | Salary | Bonus | Stock awards | Other | Total | vs. prior year |
|---|---|---|---|---|---|---|
| Daniel Burton Chief Executive Officer | $525.00K | – | $3.44M | $22.12K | $3.99M | -27% |
| Jason Alger Chief Financial Officer | $353.13K | – | $1.62M | $12.24K | $1.99M | +54% |
| Benjamin Albert Chief Operating Officer and President | $343.72K | $587.61K | $2.09M | $6.56K | $3.03M | – |
| Kevin Freeman Chief Commercial Officer | $395.63K | – | $1.40M | $14.71K | $1.81M | -16% |
| Benjamin Landry General Counsel | $410.00K | – | $928.13K | $9.04K | $1.35M | -14% |
| Dan LeSueur Former Chief Operating Officer | $255.00K | – | $1.39M | $118.67K | $1.76M | – |
Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.
IPO
From the final prospectus (Form 424B4) and the first day of trading
Offering
- Type
- Initial public offering
- Final prospectus filed
- Jul 25, 2019
- Offer price
- $26.00
- Securities offered
- 7,000,000
- Gross proceeds
- $182.00M
- Exchange
- Nasdaq
- First trading day
- Jul 25, 2019
- First-day close
- $39.17+50.7%
- Lock-up ends (est.)
- Jan 21, 2020
“The initial public offering price per share is $26.00.”
Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.
Employees
Headcount reported in annual reports
“As of December 31, 2025, we had more than 1,200 team members, the vast majority of whom are located in the United States and approximately 16% of whom are located in India.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Aug 6, 2026 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Jul 25, 2019 | IPO | Initial public offering priced (424B4 prospectus) |
| Jul 18, 2019 | Listing | Registration of securities on an exchange (Form 8-A) |
| Feb 19, 2016 | Name change | Name changed from HQC Holdings, Inc. to Health Catalyst, Inc. |
See a number that looks wrong?